(Q77892288)
Statements
Risedronate, a highly effective, short-term oral treatment for Paget's disease: a dose-response study (English)
J P Brown
D J Hosking
L Ste-Marie
C C Johnston
J Reginster
W G Ryan
T D Johnson
1 February 1999